Product

Licence-In

Image Product Name API Name Last Drug Patent Expires Details Year of start producing
CAS No.350-03-8 CAS No.350-03-8 View detail »
CAS No.7789-59-5 CAS No.7789-59-5 View detail »
CAS No.3162-58-1 CAS No.3162-58-1 View detail »
CAS No.39856-50-3 CAS No.39856-50-3 View detail »
CAS No.761-01-3 CAS No.761-01-3 View detail »
CAS No.121-52-8 CAS No.121-52-8 View detail »
CAS No.452-58-4 CAS No.452-58-4 View detail »
CAS No.43156-47-4 CAS No.43156-47-4 Fenbendazole / 芬苯达唑 View detail »
CAS No.26412-87-3 CAS No.26412-87-3 View detail »
CAS No.626-05-1 CAS No.626-05-1 View detail »
CAS No.504-29-0 CAS No.504-29-0 Dabigatran Etexilate / 达比加群酯, Acalabrutinib / 阿卡替尼 1/20/2031 （Dabigatran Etexilate）， 7/1/2036 （Acalabrutinib） View detail »
CAS No.6928-85-4 CAS No.6928-85-4 Rifamycin / 利福霉素， Streptomycin / 链霉素 5/3/2025 (Rifamycin) View detail »
CAS No.39919-65-8 CAS No.39919-65-8 View detail »
CAS No.1603-40-3 CAS No.1603-40-3 View detail »
CAS No.5308-25-8 CAS No.5308-25-8 Vardenafil / 伐地那非, Infigratinib / 西非替尼, Abemaciclib / 阿贝西利 12/23/2028 （Vardenafil）; 12/11/2034 (Infigratinib); 12/15/2029 (Abemaciclib) View detail »
CAS No.141-86-6 CAS No.141-86-6 View detail »
CAS No.695-34-1 CAS No.695-34-1 View detail »
CAS No.16013-85-7 CAS No.16013-85-7 View detail »
CAS No.7789-60-8 CAS No.7789-60-8 View detail »
CAS No.1824-81-3 CAS No.1824-81-3 View detail »